Enhanced platelet release reaction and increased thromboxane generation in esophageal achalasia and selective in vitro inhibition of arachidonic acid induced platelet aggregation by vasoactive intestinal peptide.
Zahavi
M
M
Department of Medicine, Tel Aviv Medical Center, Israel.
Rozen
P
P
Zahavi
J
J
D000328:Adult; D000368:Aged; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D004931:Esophageal Achalasia / Q000097:blood*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D013929:Thromboxane B2 / Q000097:blood; D014660:Vasoactive Intestinal Peptide / Q000494:pharmacology / Q000502:physiology; D001620:beta-Thromboglobulin / Q000378:metabolism
D001095:Arachidonic Acids; D010975:Platelet Aggregation Inhibitors; D001620:beta-Thromboglobulin; D016718:Arachidonic Acid; D014660:Vasoactive Intestinal Peptide; D013929:Thromboxane B2